|
Market Closed -
Japan Exchange
10:30:00 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,490.00 JPY | +0.81% |
|
-0.04% | +14.61% |
| 09-02 | Ono Pharmaceutical Co., Ltd. Enters Into Drug Discovery Partnership With Aitia, Inc | CI |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| Market Cap | 1,170B 7.37B 6.36B 5.99B 5.46B 10.21B 697B 10.28B 70.96B 27.54B 356B 27.69B 27.09B | P/E 2027 * |
15.9x | P/E 2028 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 969B 6.11B 5.27B 4.96B 4.52B 8.45B 577B 8.52B 58.76B 22.81B 295B 22.93B 22.43B | EV / Sales 2027 * |
2.11x | EV / Sales 2028 * | 2.05x |
| Free-Float |
81.92% | Yield 2027 * |
3.17% | Yield 2028 * | 3.13% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4528 | Delayed | |
OTC Markets
| OPHLF | Delayed | |
|
Tradegate
| ON4 | Real-time | |
|
Börse Stuttgart
| ON4 | Delayed | |
|
Boerse Muenchen
| ON4 | Real-time | |
|
Deutsche Boerse AG
| ON4 | Delayed |
Last Transcript : Ono Pharmaceutical Co., Ltd.
| 1 day | +0.81% | ||
| 1 week | -0.04% | ||
| Current month | +1.61% | ||
| 1 month | +4.45% | ||
| 3 months | +12.34% | ||
| 6 months | -2.10% | ||
| Current year | +14.61% |
| 1 week | 2,424 |  | 2,511 |
| 1 month | 2,264.5 | | 2,517.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,674 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 01/04/2024 |
Masaki Ito
DFI | Director of Finance/CFO | - | 01/04/2026 |
Toichi Takino
PSD | President | 57 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 01/04/2024 |
Toichi Takino
BRD | Director/Board Member | 57 | 01/06/2020 |
Masao Nomura
BRD | Director/Board Member | 77 | 26/06/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.81% | -0.04% | +45.87% | -10.06% | 7.32B | |
| -0.81% | +0.14% | +21.37% | +72.78% | 49.06B | |
| +0.41% | +0.12% | +52.20% | +121.38% | 40.37B | |
| -0.97% | -3.88% | +13.37% | +84.21% | 12.19B | |
| -1.28% | -1.78% | -11.64% | +12.58% | 12.08B | |
| +0.57% | +0.95% | +29.02% | +153.11% | 9.14B | |
| +0.08% | -4.12% | +24.01% | +43.45% | 7.36B | |
| -0.04% | -0.04% | +22.68% | +222.92% | 7.35B | |
| +0.03% | -1.75% | -40.80% | +14.39% | 5.19B | |
| +1.13% | -0.63% | +37.68% | +104.77% | 4.6B | |
| Average | -0.01% | -0.44% | +19.38% | +81.95% | 15.47B | |
| Weighted average by Cap. | -0.22% | +0.30% | +26.41% | +87.23% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 458B 2.89B 2.49B 2.35B 2.14B 4B 273B 4.03B 27.8B 10.79B 140B 10.85B 10.61B | 448B 2.83B 2.44B 2.3B 2.09B 3.91B 267B 3.94B 27.19B 10.55B 137B 10.61B 10.38B |
| Net income | 72.89B 459M 396M 373M 340M 636M 43.4B 641M 4.42B 1.72B 22.19B 1.73B 1.69B | 63.15B 398M 343M 323M 295M 551M 37.6B 555M 3.83B 1.49B 19.22B 1.49B 1.46B |
| Net Debt | -201B -1.27B -1.09B -1.03B -939M -1.75B -120B -1.77B -12.2B -4.73B -61.22B -4.76B -4.66B | -250B -1.57B -1.36B -1.28B -1.17B -2.18B -149B -2.19B -15.14B -5.88B -76.01B -5.91B -5.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | ¥2,490.00 | +0.81% | 1,481,700 |
| 02/09/26 | ¥2,470.00 | -0.62% | 1,460,800 |
| 01/09/26 | ¥2,485.50 | +1.43% | 1,029,200 |
| 31/08/26 | ¥2,450.50 | -0.26% | 1,569,500 |
| 28/08/26 | ¥2,457.00 | +0.04% | 1,269,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
